» Articles » PMID: 16923339

Efficient Inhibition of Human Telomerase Activity by Antisense Oligonucleotides Sensitizes Cancer Cells to Radiotherapy

Overview
Specialty Pharmacology
Date 2006 Aug 23
PMID 16923339
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To investigate the effect of the antisense oligonucleotides (ASODN) specific for human telomerase RNA (hTR) on radio sensitization and proliferation inhibition in human neurogliocytoma cells (U251).

Methods: U251 cells were transfected with hTR ASODN or nonspecific oligonucleotides (NSODN). Before and after irradiation of (60)Co- gamma ray, telomerase activity was assayed by telomeric repeat amplification protocol ( TRAP-PCR-ELISA), and DNA damage and repair were examined by the comet assay. The classical colony assay was used to plot the cell-survival curve, to detect the D(0 )value.

Results: hTR antisense oligonucleotides could downregulate the telomerase activity, increase radiation induced DNA damage and reduce the subsequent repair. Furthermore, it could inhibit the proliferation and decrease the D(0 ) value which demonstrates rising radiosensitivity. However, telomere length was unchanged over a short period of time.

Conclusion: These findings suggest that an ASODN-based strategy may be used to develop telomerase inhibitors, which can efficiently sensitize radiotherapy.

Citing Articles

Senescence of Tumor Cells in Anticancer Therapy-Beneficial and Detrimental Effects.

Piskorz W, Cechowska-Pasko M Int J Mol Sci. 2022; 23(19).

PMID: 36232388 PMC: 9570404. DOI: 10.3390/ijms231911082.


Oligonucleotide-Functionalized Gold Nanoparticles for Synchronous Telomerase Inhibition, Radiosensitization, and Delivery of Theranostic Radionuclides.

Bavelaar B, Song L, Jackson M, Able S, Tietz O, Skaripa-Koukelli I Mol Pharm. 2021; 18(10):3820-3831.

PMID: 34449222 PMC: 8493550. DOI: 10.1021/acs.molpharmaceut.1c00442.


Possibility of inducing tumor cell senescence during therapy.

Wang G, Cheng X, Zhang J, Liao Y, Jia Y, Qing C Oncol Lett. 2021; 22(1):496.

PMID: 33981358 PMC: 8108274. DOI: 10.3892/ol.2021.12757.


Silencing hTERT attenuates cancer stem cell-like characteristics and radioresistance in the radioresistant nasopharyngeal carcinoma cell line CNE-2R.

Chen K, Li L, Qu S, Pan X, Sun Y, Wan F Aging (Albany NY). 2020; 12(24):25599-25613.

PMID: 33234740 PMC: 7803545. DOI: 10.18632/aging.104167.


Radiolabeled Oligonucleotides Targeting the RNA Subunit of Telomerase Inhibit Telomerase and Induce DNA Damage in Telomerase-Positive Cancer Cells.

Jackson M, Bavelaar B, Waghorn P, Gill M, El-Sagheer A, Brown T Cancer Res. 2019; 79(18):4627-4637.

PMID: 31311806 PMC: 7611324. DOI: 10.1158/0008-5472.CAN-18-3594.